In a previous study, increased survivin/BIRC5 expression was reported in megakaryocytes from MPN patients (ET, PV, and PMF) compared to healthy donors, which was independent of the presence of JAK2V617F and CALR indel mutations.23 This evidence concerns the gene CALR and acquired polycythemia vera.